Endocrinology, Vol 97, 825-833, Copyright © 1975 by Endocrine Society

ARTICLES

Induction of human endometrial estradiol dehydrogenase by progestins

L Tseng and E Gurpide

Estradiol-17beta dehydrogenase activity in proliferative human endometrium (average of 1.5 nmole of estrone formed from estradiol/mg protein/h) was stimulated as much as as 6-fold during incubations of tissue slices in culture medium containing progesterone. Stimulation was already detectable at 7 h and the highest activity values were reached at 48-72 h of incubation in the presence of excess progesterone. Maximal stimulation was achieved with concentrations of the hormone of 0.25 mug/ml or higher. At concentrations approximately equal to midluteal plasma levels (20 ng/ml) more than 50% of the maximal response was observed. Norgestrel (17alpha-ethynyl-18-methyl-19- nortestosterone) was also effective in inducing enzymatic activity. The similarity of the effects obtained with progesterone (a possible substrate for estradiol dehydrogenase) and the synthetic progestin indicates that the stimulation of enzymatic activity was not due to substrate induction. Addition of estradiol to the culture medium had no influence on the activity of the enzyme. The induction of estradiol dehydrogenase by progesterone was inhibited by puromycin or actinomycin D. These observations indicate that progestational agents increase the rate of de novo synthesis of the enzyme. Stimulation of endometrial estradiol dehydrogenase was also observed after 2-3 day oral administration of medroxyprogesterone acetate to women in the follicular phase. In contrast, the enzymatic activity in endometrium obtained from women taking estrogens was found to be as low as in normal proliferative tissue. These in vitro and in vivo results point to progesterone as the agent responsible for the 10-fold increase in endometrial estradiol dehydrogenase activity observed during the luteal phase in menstruating women. Data obtained from superfusion studies of estrogen dynamics in endometrium indicate that changes in enzyme concentrations may play a physiologic role in the regulation of tissue levels of estradiol.

This article has been cited by other articles:

				H. Dassen, C. Punyadeera, R. Kamps, B. Delvoux, A. Van Langendonckt, J. Donnez, B. Husen, H. Thole, G. Dunselman, and P. Groothuis Estrogen metabolizing enzymes in endometrium and endometriosis Hum. Reprod., December 1, 2007; 22(12): 3148 - 3158. [Abstract] [Full Text] [PDF]

				P Hanifi-Moghaddam, B Sijmons, M C Ott, W F J van IJcken, D Nowzari, E C M Kuhne, P van der Spek, H J Kloosterboer, C W Burger, and L J Blok The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line J. Mol. Endocrinol., December 1, 2006; 37(3): 405 - 413. [Abstract] [Full Text] [PDF]

				W. Zhang, J. Mazella, H. J. Kloosterboer, and L. Tseng Progestagenic Effects of Tibolone are Target Gene--Specific In Human Endometrial Cells Reproductive Sciences, September 1, 2006; 13(6): 459 - 465. [Abstract] [PDF]

				P. Hanifi-Moghaddam, S. C. J. P. Gielen, H. J. Kloosterboer, M. E. De Gooyer, A. M. Sijbers, A. J. van Gool, M. Smid, M. Moorhouse, F. H. van Wijk, C. W. Burger, et al. Molecular Portrait of the Progestagenic and Estrogenic Actions of Tibolone: Behavior of Cellular Networks in Response to Tibolone J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 973 - 983. [Abstract] [Full Text] [PDF]

				K. Zhang and P. K. H. Chow The Effect of Megestrol Acetate on Growth of HepG2 Cells In vitro and In vivo Clin. Cancer Res., August 1, 2004; 10(15): 5226 - 5232. [Abstract] [Full Text] [PDF]

				G. E. Hale, C. L. Hughes, and J. M. Cline Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15. [Abstract] [Full Text] [PDF]

				S. Yang, Z. Fang, B. Gurates, M. Tamura, J. Miller, K. Ferrer, and S. E. Bulun Stromal PRs Mediate Induction of 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Expression in Human Endometrial Epithelium: A Paracrine Mechanism for Inactivation Of E2 Mol. Endocrinol., December 1, 2001; 15(12): 2093 - 2105. [Abstract] [Full Text] [PDF]

				J. Kitawaki, H. Koshiba, H. Ishihara, I. Kusuki, K. Tsukamoto, and H. Honjo Progesterone Induction of 17{beta}-Hydroxysteroid Dehydrogenase Type 2 during the Secretory Phase Occurs in the Endometrium of Estrogen-Dependent Benign Diseases But Not in Normal Endometrium J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3292 - 3296. [Abstract] [Full Text]

				G. R. ATTIA, K. ZEITOUN, D. EDWARDS, A. JOHNS, B. R. CARR, and S. E. BULUN Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2897 - 2902. [Abstract] [Full Text]

				G. L. Rubin, A. J. Harrold, J. A. Mills, C. N. Falany, and M. W.H. Coughtrie Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy Mol. Hum. Reprod., November 1, 1999; 5(11): 995 - 1002. [Abstract] [Full Text] [PDF]

				V. P. Fomin, B. E. Cox, and R. A. Word Effect of progesterone on intracellular Ca2+ homeostasis in human myometrial smooth muscle cells Am J Physiol Cell Physiol, February 1, 1999; 276(2): C379 - C385. [Abstract] [Full Text] [PDF]

				K. Zeitoun, K. Takayama, H. Sasano, T. Suzuki, N. Moghrabi, S. Andersson, A. Johns, L. Meng, M. Putman, B. Carr, et al. Deficient 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17{beta}-Estradiol J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4474 - 4480. [Abstract] [Full Text]

				W. B. Kowalski, R. F. Valle, and R. T. Chatterton Jr. Response of the Primate Secretory Endometrium to Subchronic Hypercortisolemia Reproductive Sciences, May 1, 1997; 4(3): 152 - 159. [Abstract] [PDF]

				F. Leenders, J. G. Tesdorpf, M. Markus, T. Engel, U. Seedorf, and J. Adamski Porcine 80-kDa Protein Reveals Intrinsic 17beta-Hydroxysteroid Dehydrogenase, Fatty Acyl-CoA-hydratase/Dehydrogenase, and Sterol Transfer Activities J. Biol. Chem., March 8, 1996; 271(10): 5438 - 5442. [Abstract] [Full Text] [PDF]

				P. Satyaswaroop, R. Zaino, and R Mortel Human endometrial adenocarcinoma transplanted into nude mice: growth regulation by estradiol Science, January 7, 1983; 219(4580): 58 - 60. [Abstract] [PDF]